# Adaptimmune Therapeutics PLC: Form 10-Q/A for the period ended Sep 30, 2016

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 10-Q/A
- Filed: 2017-04-06
- Accepted by EDGAR: Apr 6, 2017, 16:39 ET
- Period: 2016-09-30
- Accession: 0001104659-17-021990
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465917021990/a17-11024_110qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465917021990/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465917021990/a17-11024_110qa.htm

Filed Apr 6, 2017.
Source: SEC EDGAR, the filing index for accession 0001104659-17-021990. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
